Literature DB >> 8223087

Antibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipids.

J Y Sung1, E A Shaffer, J W Costerton.   

Abstract

In vitro studies have demonstrated that bile salts have cytotoxic and bacteriostatic properties. The cytotoxic effect of bile salts is reduced when lecithin is added. The effect of lecithin on the bacteriostatic property of bile salts is not known. In this report, we test the hypotheses that (1) the bacteriostatic activity of bile salts is a function of the hydrophobicity of the molecules, and (2) lecithin, by engaging the hydrophobic component of bile salts, attenuates the bacteriostatic property of these molecules. Two common biliary pathogens, Escherichia coli and Enterococcus fecalis, were tested in this experiment. The results demonstrate that hydrophobic bile salts (sodium taurodeoxycholate, sodium deoxycholate) have more significant inhibition on the growth of bacteria when compared with the hydrophilic bile salts (sodium taurocholate, sodium chenodeoxycholate, and sodium tauroursodeoxycholate). When lecithin is added, creating a mixed micellar solution and mimicking the in vivo conditions, the antibacterial activities of even the more potent bacteriostatic bile salts are significantly reduced. The finding that lecithin significantly attenuates the bacteriostatic property of even the hydrophobic bile salts raises questions about the clinical significance of such bacteriostatic effect in vivo; as bile salts in the bile exist in mixed micellar solution.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223087     DOI: 10.1007/bf01297092

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

Review 1.  Defense system in the biliary tract against bacterial infection.

Authors:  J Y Sung; J W Costerton; E A Shaffer
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

2.  Cholic acid inhibition of intestinal bacteria.

Authors:  M H Floch; W Gershengoren; S Diamond; T Hersh
Journal:  Am J Clin Nutr       Date:  1970-01       Impact factor: 7.045

Review 3.  Bile salts and biliary lipids.

Authors:  R Coleman
Journal:  Biochem Soc Trans       Date:  1987-12       Impact factor: 5.407

4.  The inhibitory effect of sodium deoxycholate on Escherichia coli.

Authors:  M E Fraser
Journal:  J Appl Bacteriol       Date:  1971-12

5.  Cell type-dependent effect of phospholipid and cholesterol on bile salt cytotoxicity.

Authors:  A L Velardi; A K Groen; R P Elferink; R van der Meer; G Palasciano; G N Tytgat
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

6.  The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities.

Authors:  M J Armstrong; M C Carey
Journal:  J Lipid Res       Date:  1982-01       Impact factor: 5.922

7.  Membrane fluidity and bile salt damage.

Authors:  P J Lowe; R Coleman
Journal:  Biochim Biophys Acta       Date:  1981-01-08

8.  Kinetics and thermodynamics of dissolution of lecithin by bile salts.

Authors:  S Lindenbaum; N Rajagopalan
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

  8 in total
  30 in total

Review 1.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

2.  How bile acids confer gut mucosal protection against bacteria.

Authors:  Alan F Hofmann; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 3.  Endoscopic stenting for palliation of malignant biliary obstruction. A review of progress in the last 15 years.

Authors:  J J Sung; S C Chung
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

Review 4.  Gut microbiota and liver diseases.

Authors:  Masami Minemura; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

5.  The microbiome modulating activity of bile acids.

Authors:  Yuan Tian; Wei Gui; Imhoi Koo; Philip B Smith; Erik L Allman; Robert G Nichols; Bipin Rimal; Jingwei Cai; Qing Liu; Andrew D Patterson
Journal:  Gut Microbes       Date:  2020-03-05

6.  A comparative evaluation of early stent occlusion among biliary conventional versus wing stents.

Authors:  Mouen A Khashab; Susan Hutfless; Katherine Kim; Anne Marie Lennon; Marcia I Canto; Sanjay B Jagannath; Patrick I Okolo; Eun Ji Shin; Vikesh K Singh
Journal:  Dig Dis Sci       Date:  2012-01-20       Impact factor: 3.199

Review 7.  Bacterial biofilm and clogging of biliary stents.

Authors:  J J Sung
Journal:  J Ind Microbiol       Date:  1995-09

Review 8.  Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

Authors:  Ekihiro Seki; Bernd Schnabl
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

9.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

10.  Management of complications associated with partially covered biliary metal stents.

Authors:  Henry Ho; Anshu Mahajan; Sonia Gosain; Animesh Jain; Andrew Brock; Michele E Rehan; Kristi Ellen; Vanessa M Shami; Michel Kahaleh
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.